https://scholars.lib.ntu.edu.tw/handle/123456789/531846
標題: | Association between dyslipidemia and residual renal function in patients on chronic peritoneal dialysis | 作者: | Chen H.-Y. Kao T.-W. JENQ-WEN HUANG TUN-JUN TSAI KWAN-DUN WU |
公開日期: | 2008 | 出版社: | Dustri-Verlag Dr. Karl Feistle | 卷: | 70 | 期: | 3 | 起(迄)頁: | 233-239 | 來源出版物: | Clinical Nephrology | 摘要: | Background: Dyslipidemia and residual renal function (RRF) have a significant impact on the cardiovascular mortality in dialysis patients, but their association in patients on chronic peritoneal dialysis (PD) has not been completely studied. Methods: 170 PD patients were divided into 2 groups based on the RRF (Group I had no RRF and Group II had RRF > 0 ml/min/1.73 m2 BSA). An observational, longitudinal study was performed to elucidate the dyslipidemic state in PD patients with different levels of RRF and the associafion of dyslipidemia and deterioration of RRF during 3 years. Results: Patients' basic characteristics and lipid profiles at the initiation of study were similar between the groups. At the end of study, Group I patients had a lower T-CHO (p = 0.001), LDL-C (p = 0.018), HDL-C (p = 0.05) and non-HDL-C (p = 0.003) than Group II. There was a significant correlation between a change in HDL-C and the decline of RRF (r = 0.177, p = 0.048) and it was independent of PD duration and levels of highly sensitive C-reactive protein (r = 0.233, p = 0.04). Conclusion: Our results clearly demonstrate the different longitudinal changes of lipid profiles in PD patients with different RRF and an association between decline of HDL-C and deterioration of RRF. ?2008 Dustri-Verlag Dr. K. Feistle. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-52149123923&doi=10.5414%2fcnp70233&partnerID=40&md5=36e07d6cb59ef21e042c1e3920362811 https://scholars.lib.ntu.edu.tw/handle/123456789/531846 |
ISSN: | 0301-0430 | DOI: | 10.5414/cnp70233 | SDG/關鍵字: | albumin; angiotensin receptor antagonist; antihypertensive agent; C reactive protein; calcium; cholesterol; creatinine; dialysis fluid; dipeptidyl carboxypeptidase inhibitor; erythropoietin; hemoglobin; high density lipoprotein cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; lipid; low density lipoprotein cholesterol; parathyroid hormone; phosphorus; potassium; uric acid; adult; aged; anemia; article; body mass; chronic glomerulonephritis; chronic kidney failure; continuous ambulatory peritoneal dialysis; controlled study; correlation analysis; creatinine clearance; deterioration; diabetes mellitus; diabetic nephropathy; diastolic blood pressure; disease association; dyslipidemia; female; human; hypertension; kidney function; longitudinal study; major clinical study; male; observational study; peritoneal dialysis; systolic blood pressure; Taiwan; treatment duration; university hospital |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。